| 27 Mar, 06:43 pm | — | … | Aarti Pharmalabs Limited has informed the Exchange regarding 'Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015'. | nse |
| 27 Mar, 06:28 pm | — | … | Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 24 Mar, 12:48 pm | — | … | Aarti Pharmalabs Limited has informed the Exchange regarding 'Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015'. | nse |
| 16 Feb, 11:04 am | — | … | Aarti Pharmalabs Limited has informed the Exchange about Transcript | nse |
| 16 Feb, 11:00 am | — | … | Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 13 Feb, 02:51 pm | — | … | Aarti Pharmalabs Limited has informed the Exchange about Clarification Regarding Delay in Disclosure of Event to the Exchange | nse |
| 10 Feb, 10:34 pm | — | … | Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 10 Feb, 10:32 pm | — | … | Aarti Pharmalabs Limited has informed the Exchange about Link of Recording | nse |
| 10 Feb, 01:47 pm | — | … | Aarti Pharmalabs Limited has informed the Exchange regarding 'Corrigendum to Intimation of Record Datefor Dividend dated February 09, 2026'. | nse |
| 10 Feb, 01:01 pm | — | … | Aarti Pharmalabs Limited has informed the Exchange about Investor Presentation | nse |
| 10 Feb, 12:55 pm | — | … | Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 09 Feb, 08:27 pm | — | … | Aarti Pharmalabs Limited has informed the Exchange that Record date for the purpose of Dividend is 16-Feb-2026. | nse |
| 09 Feb, 08:21 pm | — | … | Aarti Pharmalabs Ltd - 543748 - Fixation Of Record Date For Interim Dividend | bse |
| 09 Feb, 08:18 pm | — | … | Aarti Pharmalabs Ltd - 543748 - Corporate Action-Board approves Dividend | bse |
| 09 Feb, 08:15 pm | — | … | Aarti Pharmalabs Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025. | nse |
| 09 Feb, 08:10 pm | — | … | Aarti Pharmalabs Ltd - 543748 - Financial Results For The Quarter And Nine Months Ended December 31, 2025 | bse |
| 09 Feb, 08:08 pm | — | … | Aarti Pharmalabs Limited has informed the Exchange that Board of Directors at its meeting held on February 09, 2026, declared Interim Dividend of Rs. 1.5 per equity share. | nse |
| 09 Feb, 08:03 pm | — | … | Aarti Pharmalabs Ltd - 543748 - Board Meeting Outcome for Outcome Of Board Meeting Held On February 9, 2026 | bse |
| 06 Feb, 04:31 pm | — | … | Aarti Pharmalabs Limited has informed the Exchange about General Updates | nse |
| 06 Feb, 04:14 pm | — | … | Aarti Pharmalabs Ltd - 543748 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 | bse |
| 29 Jan, 02:51 pm | — | … | Aarti Pharmalabs Ltd - 543748 - Board Meeting Intimation for 1. Board Meeting Intimation For Unaudited Financial Results Of The Company For The Quarter And Nine-Months Ended December 31, 2025
2. Declaration Of Interim Dividend, If Any, On The Equity Share Capital Of The Company For The Financial Year 2025-26. | bse |
| 12 Jan, 02:52 pm | — | … | Significant increase in volume has been observed in Aarti Pharmalabs Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Aarti Pharmalabs Limited has submitted their response. | nse |
| 12 Jan, 02:44 pm | — | … | Aarti Pharmalabs Ltd - 543748 - Clarification With Respect To Increase In Volume | bse |
| 12 Jan, 12:18 pm | — | … | Aarti Pharmalabs Ltd - 543748 - Clarification sought from Aarti Pharmalabs Ltd | bse |
| 09 Jan, 06:30 pm | — | … | Significant increase in volume has been observed in Aarti Pharmalabs Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited. | nse |
| 01 Jan, 05:09 pm | — | … | Aarti Pharmalabs Limited has informed the Exchange about change in Management | nse |
| 01 Jan, 05:03 pm | — | … | Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 17 Nov, 05:37 pm | — | … | Aarti Pharmalabs Limited has informed the Exchange about Transcript | nse |
| 17 Nov, 05:29 pm | — | … | Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 11 Nov, 06:42 pm | — | … | Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 11 Nov, 06:24 pm | — | … | Aarti Pharmalabs Limited has informed the Exchange about Link of Recording | nse |
| 11 Nov, 08:22 am | — | … | Aarti Pharmalabs Limited has informed the Exchange about Investor Presentation | nse |
| 11 Nov, 08:18 am | — | … | Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 09 Nov, 04:27 pm | — | … | Aarti Pharmalabs Ltd - 543748 - Financial Results For Quarter And Half Year Ended September 30, 2025 | bse |
| 09 Nov, 03:32 pm | — | … | Aarti Pharmalabs Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025. | nse |
| 09 Nov, 03:25 pm | — | … | Aarti Pharmalabs Ltd - 543748 - Board Meeting Outcome for Board Meeting Outcome For Financial Results For The Quarter And Half Year Ended September 30, 2025. | bse |
| 09 Nov, 03:24 pm | — | … | Aarti Pharmalabs Ltd - 543748 - Board Meeting Outcome for Board Meeting Outcome For Financial Results For The Quarter And Half Year Ended September 30, 2025. | bse |
| 09 Nov, 02:06 pm | — | … | Aarti Pharmalabs Limited has informed the Exchange about change in Management | nse |
| 09 Nov, 02:02 pm | — | … | Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 04 Nov, 06:31 pm | — | … | Aarti Pharmalabs Limited has informed the Exchange about Schedule of meet on Tuesday, November 11, 2025 at 4:00 P.M. (IST) to discuss the Company's Q2-FY26 Financial Results. | nse |
| 27 Oct, 04:36 pm | — | … | Aarti Pharmalabs Ltd - 543748 - Board Meeting Intimation for Board Meeting Intimation For Approval Of Unaudited Standalone And Consolidated Financial Results For The Second Quarter And Half Year Ended September 30, 2025 | bse |
| 15 Oct, 03:28 pm | — | … | The Exchange had sought clarification from Aarti Pharmalabs Limited for the quarter ended 30-Jun-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: The response of the Company is enclosed. | nse |
| 08 Oct, 10:58 am | — | … | Aarti Pharmalabs Limited has informed the Exchange about General Updates | nse |
| 08 Oct, 10:56 am | — | … | Aarti Pharmalabs Ltd - 543748 - Ex-Parte Ad-Interim Injunction Order Regarding Pharmaceutical Drug Product Containing Ruxolitinib And/Or Ruxolitinib Phosphate API | bse |
| 24 Sept, 10:23 am | — | … | Aarti Pharmalabs Ltd - 543748 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 | bse |
| 23 Sept, 07:56 pm | — | … | Aarti Pharmalabs Limited has informed the Exchange about Investor Presentation | nse |
| 23 Sept, 07:53 pm | — | … | Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 23 Sept, 07:44 pm | — | … | Aarti Pharmalabs Limited has informed the Exchange about change in Management | nse |
| 23 Sept, 07:36 pm | — | … | Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 08 Sept, 03:28 pm | — | … | The Exchange has sought clarification from Aarti Pharmalabs Limited for the quarter ended 30-Jun-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted in XBRL with discrepancies The response of the Company is awaited. | nse |